ETF Series Solutions Trust Range Cancer Therapeutics ETFCNCR
CNCR
$15.82
3.67%
Market Cap: 18.7M
0
Funds holding %
of 6,702 funds
–
Analysts bullish %
–
News positive %
Fund manager confidence
Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
24% more capital invested
Capital invested by funds: $1.7M [Q4 2023] → $2.12M (+$418K) [Q1 2024]
8% more funds holding
Funds holding: 13 [Q4 2023] → 14 (+1) [Q1 2024]
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
2.69% less ownership
Funds ownership: 12.28% [Q4 2023] → 9.6% (-2.69%) [Q1 2024]
Research analyst outlook
We haven’t received any recent analyst ratings for CNCR.